Abstract We previously reported that in healthy mouse cerebral arteries, endothelial nitric oxide synthase (eNOS) produces H 2 O 2 , leading to endothelium-dependent dilation. In contrast, thromboxane A 2 (TXA 2 ), a potent pro-oxidant and pro-inflammatory endogenous vasoconstrictor, is associated with eNOS dysfunction. Our objectives were to elucidate whether (1) the cerebrovascular eNOS-H 2 O 2 pathway was sensitive to oxidative stress associated with aging and dyslipidemia and (2) TXA 2 contributed to cerebral eNOS dysfunction. Atherosclerotic (ATX = LDLR −/− ; hApoB +/+ ) and wild-type (WT) control mice were used at 3 and 12 months old (m/o). Three-m/o ATX mice were treated with the cardio-protective polyphenol catechin for 9 months. Dilations to ACh and the simultaneous eNOS-derived H 2 O 2 production were recorded in isolated pressurized cerebral arteries. The age-associated decrease in cerebral eNOS-H 2 O 2 pathway observed in WT was premature in ATX mice, decreasing at 3 m/o and abolished at 12 m/o. Thromboxane synthase inhibition by furegrelate increased dilations at 12 months in WT and at 3 and 12 months in ATX mice, suggesting an anti-dilatory role of TXA 2 with age hastened by dyslipidemia. In addition, the non-selective NADP(H) oxidase inhibitor apocynin improved the eNOS-H 2 O 2 pathway only in 12-m/o ATX mice. Catechin normalized the function of this pathway, which became sensitive to L-NNA and insensitive to furegrelate or apocynin; catechin also prevented the rise in TXA 2 synthase expression. In conclusion, the agedependent cerebral endothelial dysfunction is precocious in dyslipidemia and involves TXA 2 production that limits eNOS activity. Preventive catechin treatment reduced the impact of endogenous TXA 2 on the control of cerebral tone and maintained eNOS function.
Introduction
We previously reported that in mouse cerebral arteries, endothelial nitric oxide synthase (eNOS), cyclooxygenase (COX), and an endothelium-derived hyperpolarizing factor (EDHF) are important regulators of vascular tone in response to ACh and flow [7, 8] . We also reported that eNOS stimulation of healthy mouse cerebral arteries leads to the production of vasodilatory H 2 O 2 and not the release of NO, showing that eNOS produces physiologically relevant levels of free radicals leading to H 2 O 2 -dependent dilation [7, 8] . This eNOS-H 2 O 2 pathway represents a nontraditional mechanism for healthy vessels and is still a subject of ongoing debate. A similar vasodilatory pathway, however, has been described in peripheral mouse and human arteries [27, 33] and human coronary arterioles [25] . The generation by eNOS of H 2 O 2 rather than NO is usually associated with eNOS uncoupling and endothelial dysfunction, and reported in a pathological situation [11] . With the brain being highly susceptible to oxidative damage [1] , one would therefore expect the arterial eNOS-H 2 O 2 pathway to be highly sensitive to the redox environment.
There is overwhelming evidence that a rise in oxidative stress is associated with aging and multiple cardiovascular diseases (CVD). Although an "apparent" protection of intracranial arteries from atherosclerosis has been reported based on the fact that atherosclerotic lesions are rarely observed in cerebral arteries from animal models [5, 49] , it is now clear that endothelial dysfunction also occurs in the cerebral circulation: atherosclerosis in ApoE −/− mice is associated with NOS dysfunction and an increase in NADP (H) oxidase activity, leading to the rise in oxidative stress and cerebral endothelial damage [20, 31, 32] . In peripheral arteries, it has been proposed that the impairment of eNOS function by oxidative stress could promote TXA 2 production, a potent vasoconstrictor with inflammatory properties, which would further contribute to the rise in ROS and endothelial dysfunction [13, 14, 57] . Serum levels of TXA 2 and thromboxane receptor expression are elevated in patients with several vascular and ischemic diseases [37] , including cerebral ischemia [2, 21, 43, 55] . In addition, a specific polymorphism in the TXA 2 synthase-1 gene has been reported in some patients with cerebral infarction [40] . TXA 2 is produced by brain tissues [9] and cerebral arteries, both in vitro [15] and in vivo [42] , and the release of TXA 2 in cerebral arteries is 10-fold higher than in coronary, mesenteric, or saphenous arteries [48] . Although reports on the contribution of TXA 2 in cerebral arteries with atherosclerosis are scarce [10] , they support a role of TXA 2 in endothelial dysfunction and the pathological control of cerebrovascular tone [42] . Despite the demonstration that inhibition of TXA 2 synthase [28] and COX activity [24] is neuroprotective in rodent models of stroke and neurodegenerative diseases, and that cardio-protective polyphenols with antioxidant properties reduce the incidence of ischemic stroke [23, 50] , the exact link between cerebral eNOS dysfunction, a rise in oxidative stress, and TXA 2 has not been defined. We hypothesized that in a pro-oxidant environment associated with aging and atherosclerosis, a dysfunction of cerebral eNOS function reduces the dilatory role of H 2 O 2 , increases the TXA 2 synthase activity, thus perpetuating the vicious circle of oxidative stress and accelerating endothelial damage. To validate this hypothesis, chronic treatment with the polyphenol catechin [12, 50, 54] and the effects of acute pharmacological TXA 2 synthase inhibition were tested in cerebral arteries isolated from middle-aged severely dyslipidemic mice. The results support the concept that with aging and dyslipidemia, eNOS dysfunction mirrors the rise in TXA 2 synthase activity, promoting cerebral endothelial dysfunction. Long-term preventive catechin treatment minimizes the decrease in eNOS activity and the rise in TXA 2 synthesis.
Materials and methods
The procedures and protocols were performed in accordance with our institutional guidelines and the Guide for the Care and Use of Laboratory Animals of Canada. We used 3-and 12-m/o C57Bl/6 male mice (WT, 29±1 g and 46±3 g, respectively, n=20; Charles River Laboratories, StConstant, QC, Canada) and 3-and 12-m/o atherosclerotic mice (ATX, 25±1 g and 39±2 g, respectively, n=20). ATX mice are knockout for the low density lipoprotein receptor (LDLR) and express the human apolipoprotein B-100 gene (LDLR −/− ; hApoB +/+ [6, 44] ). Founders of the colony were generous gifts from Dr. H. Hobbs (University of Texas Southwestern, Dallas, TX, USA). An additional group of ATX mice received catechin (CAT, 98% purity; SigmaAldrich, Oakville, ON, Canada) for 9 months (from 3 to 12 m/o, n=20) in the drinking water (ATX+CAT; 30 mg/ kg/day), as previously described [12] and to provide an appropriate dietary intake of ≈0.75 mg/day and per mouse of catechin ( [18, 26, 34, 56] ; see also comment in the supplementary data). All mice were fed with a normal standard diet (Harlan Laboratories, Tecklad 2014S, Montreal, QC, Canada) since ATX mice spontaneously develop atherosclerotic lesions.
Systemic pressure and plasma parameters At the age of 3 and 12 months, mice were sacrificed by exsanguination under deep anesthesia (isoflurane) after monitoring heart rate and blood pressure using a Millar catheter inserted into the left carotid artery. Isoflurane anesthesia has no impact on vascular reactivity in isolated cerebral arteries (data not shown). Plasma was collected from blood sample and frozen at −80°C. Total cholesterol, LDL, and triglycerides were measured in the hospital biochemical laboratory. Plasma levels of the stable metabolite of TXA 2 (11-dehydro-thromboxane B 2 , TXB 2 ) were quantified using an ELISA according to the protocol provided by the manufacturer (Cayman Chemical, Ann Arbor, MI, USA).
Plaque area quantification Thoracic aortas were removed from the mice and carefully dissected from surrounding tissues. The vessels were opened, pinned, and a picture was taken. Plaque area quantification was calculated with Photoshop software and expressed in percentage of total aortic area [6] .
Quantification of oxidative stress Concomitant with aortic plaque quantification, the oxidative fluorescent probe dihydroethidium (DHE, 5 μmol/l; Sigma-Aldrich Canada) was used to evaluate global in situ oxidative stress on 14-μm sections of unfixed frozen aorta [12] . In addition, brain sections containing the basilar artery were processed similarly to evaluate cerebrovascular oxidative stress [6] . DNA counterstaining was performed using ToPro-3 (2 μM; Molecular Probe, Burlington, ON, Canada). Computerbased analysis was performed using Image J software and data are expressed as average fluorescence per nucleus.
Experimental design for reactivity studies The brain was rapidly removed from the cranial cavity and placed in icecold physiological salt solution (PSS) of the following composition (mM): NaCl 130, KCl 4.7, CaCl 2 1.6, MgSO 4 1.17, NaHCO 3 14.9, KH 2 PO 4 1.18, EDTA 0.026, and glucose 10. As previously described [6] [7] [8] , cerebral arteries from the circle of Willis were isolated, cannulated at both ends (average internal diameter of 136±2 μm; n=60), and pressurized at 60 mmHg in no-flow condition in PSS oxygenated by a gas mixture containing 12% O 2 , 5% CO 2 , and 83% of N 2 , generating a pO 2 of 150±10 mmHg. An equilibration period of 40 min was allowed before starting the experiments, time during which myogenic tone (MT) develops. The vessels were contracted with phenylephrine (PE; 10 to 30 μmol/l) to obtain a similar pre-constriction level (of 40-50%). Then, a single cumulative concentration-response curve to acetylcholine (ACh, 0.1 nM to 30 μM) was performed on each segment. In some protocols, the arteries were pre-treated for 30 min with (1) N w -nitro-L-arginine (L-NNA; 10 μmol/l), a NOS inhibitor; (2) indomethacin (INDO; 10 μmol/l), a COX inhibitor; (3) furegrelate (FUR; 10 μmol/l), a potent TXA 2 synthase inhibitor [13] ; or (4) apocynin (APO; 10 μmol/l), a nonspecific NADP(H) oxidase inhibitor. PE, ACh, INDO, FUR, APO, and L-NNA were purchased from SigmaAldrich Canada Ltd. The maximal diameter (D max ) was determined by changing the PSS to a Ca 2+ -free PSS; MT and dilations were expressed as percentage of the D max [6] [7] [8] . Half-maximum effective concentration (EC 50 ) of ACh was measured from each individual concentration-response curve using a logistic curve-fitting program (Allfit; Dr André De Léan, Université de Montreal, QC, Canada). Vascular sensitivity (pD 2 ) values, the negative log of the EC 50 , were obtained. [8] and we reported the method to measure simultaneously the dilation and the production of H 2 O 2 , using a fluorescent probe, the 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate acetyl ester (DCF-DA, Molecular Probe). In our model, DCF-DA is specific for H 2 O 2 [7, 8] . Fluorescence intensities (λ Ex 492-495 nm) were measured at 520 nm with an IonOptix Acquire system (IonOptix, Milton, MA, USA). Before each experiment, basal fluorescence intensity was recorded. The increase in fluorescence associated with ACh stimulation was calculated as the difference between the intensity of DCF-DA fluorescence in the presence of ACh and the intensity of DCF-DA fluorescence in the presence of PE.
Western blots Whole brain vessels were isolated as previously described [22] . Briefly, two brains from each group were pooled, homogenized with a loosely fitting Dounce tissue grinder in ice-cold phosphate buffer saline (PBS, pH 7.4), and centrifuged at 3,500 rpm for 5 min at 4°C. The pellet was then suspended in PBS, gently layered over 15% dextran solution (molecular mass, 43 kDa), and finally centrifuged at 5,000 rpm for 30 min at 4°C. Pellets containing blood vessels were collected over a 50-μm nylon mesh. Proteins were isolated from the vessels following 30-min incubation in a lysis buffer of the following composition (mM): Tris-HCl 50, β-glycerophosphate 20, NaF 20, EDTA 5, EGTA 10, Na 3 VO 4 1, benzamidin 10, dithiothreitol 5, PMSF 0.5, leupeptin 0.02, microcystin LR 1, and Triton X-100 1% (v/v). For Western blot analysis, proteins (50 μg/lane) were subjected to SDS-PAGE, using a discontinuous buffer system (Laemmli), in 10-20% gradient gels and transferred to nitrocellulose. Blots were incubated with the primary antibodies [rabbit polyclonal anti-endothelial NOS (eNOS), 1:200, BD Transduction Laboratories, Franklin Lakes, NJ, USA; rabbit polyclonal anti-inducible NOS (iNOS), 1:1,000, Santa Cruz Biotechnology, Santa Cruz, CA, USA; rabbit polyclonal anti-COX-1, 1:1,000, Cayman Chemical, Arbor, MI, USA; rabbit polyclonal anti-COX-2, 1:1,000, Cayman Chemical; goat polyclonal anti-PGI 2 synthase, 1:200, Santa Cruz Biotechnology; and rabbit polyclonal anti-TXA 2 synthase, 1:1,000, Abcam, Cambridge, MA, USA]. Equal protein loading was established with GAPDH (mouse monoclonal anti-GAPDH, 1:100,000, Ambion, Streetville, ON, Canada) or with α smooth muscle actin (mouse monoclonal anti-α smooth muscle actin, α SMA, 1:100,000, Sigma-Aldrich Canada).
Statistics "n" refers to the number of animals used in each protocol. Continuous variables are expressed as mean± standard error (SEM). One-way ANOVA followed by Tukey's test as post hoc test was used to compare each parameter among the different groups of mice. Unpaired t test was performed to study the effects of L-NNA, FUR, APO, and INDO on ACh-induced dilations, MT, and H 2 O 2 -fluorescence increase. The results were considered to be statistically significant when the p value was <0.05.
Results
Heart rate and blood pressure Heart rate was not affected by age in WT but it tended to decrease (p=0.06) in 12-m/o ATX mice (Table 1) . Arterial blood pressure increased with age in both WT and ATX mice. At 3 months, however, ATX mice were already hypertensive compared to WT mice (Table 1) . Catechin maintained blood pressure to values measured in 3-m/o WT without affecting heart rate at 12 months (Table 1) . Arterial blood pressure was routinely measured and compared in animals under isoflurane anesthesia (Table 1) and also in non-anesthetized animals by the tail-cuff technique (6-m/o ATX mice were hypertensive when compared to WT mice, systolic blood pressure=128±2 versus 146±3 mmHg, WT versus ATX mice, n=8, p<0.05). In 6-m/o conscious mice, HR was not affected by age or dyslipidemia (666±10 versus 682±12 bpm, WT versus ATX mice, n=8, p>0.05). It is apparent that isoflurane anesthesia significantly depressed HR and blood pressure.
Plasma parameters ATX mice were severely dyslipidemic at both 3 and 12 months of age compared to WT mice (Table 1) ; as expected, catechin did not modify cholesterol and triglycerides levels ( Table 1) . Of interest, cholesterol rose with age in WT mice, essentially due to a rise in LDL cholesterol (Table 1) . Plasma thromboxane B 2 (the stable metabolite of TXA 2 ) levels were unaffected by age or dyslipidemia (Table 1) . Following catechin treatment, however, TXB 2 levels were reduced by 80% in the plasma of ATX mice (Table 1) .
Plaque area and oxidative stress WT mice did not develop atherosclerotic plaque with age, in contrast to ATX mice ( Supplementary Fig. S1 ). Catechin significantly reduced plaque formation by 35% (Fig. S1 ). Atherosclerotic lesions were also present in the carotid arteries from middle-aged ATX mice. In contrast, lesions or fatty deposits were observed only occasionally in cerebral arteries from ATX mice (data not shown). Global vascular oxidative stress, assessed by aortic DHE staining, was significantly higher in 12-m/o compared to 3-m/o WT mice (Fig. 1a) . DHE staining was already greater at 3 months in ATX than in WT mice but did not increase further with age. Catechin normalized oxidative stress in 12-m/o ATX mice to 3-m/o WT values (Fig. 1a) . In cerebral arteries, DHE staining was similar between 3-m/o WT and ATX mice (Fig. 1b) , as previously reported [6] . In contrast to aortic-DHE staining, superoxide staining in cerebral arteries decreased in 12-m/o ATX mice and was not affected by catechin (Fig. 1b) . The physiological response of resistance arteries to a rise in intra-luminal pressure is an increase in MT, i.e., a reduction in diameter. The MT of cerebral arteries induced by a pressure of 60 mmHg was greater in ATX than in WT mice at both ages, while aging alone had no effect (Fig. 2a) . L-NNA increased MT in cerebral arteries isolated from WT mice only, suggesting an impaired basal eNOS activity in ATX mice (Fig. 2a) . The increased MT in arteries isolated from ATX mice was eliminated by INDO or FUR, while these agents had no effect on MT in WT mice, suggesting a role for TXA 2 in the elevated MT in ATX mice. After 9 months of treatment with catechin, MT of vessels isolated from ATX mice was normalized to WT values, sensitive to L-NNA and unaffected by INDO or FUR (Fig. 2a) , demonstrating a reversal of the eNOS dysfunction and a reduction in TXA 2 -dependent regulation of cerebrovascular MT.
Decline in cerebral eNOS function and up-regulation of TXA 2 with age and atherosclerosis
In cerebral arteries isolated from 3-m/o WT mice, ACh induced endothelium-dependent dilations (pD 2 of 7.0±0.2 and E max of 48±4%; Table 2 ) and we previously reported that eNOS-derived H 2 O 2 production is a key endotheliumderived relaxing factor in young and healthy mouse cerebral arteries [8] . We therefore investigated eNOS function by simultaneous recording ACh-mediated dilations and H 2 O 2 production (Figs. 2b-c, 3 , and 4). With age, efficacy to ACh decreased by ≈50% in arteries from WT mice and dilations were almost abolished in middle-aged ATX mice (Fig. 2b, Table 2 ). Accordingly, H 2 O 2 production was reduced in 12-m/o WT mice and in ATX mice when compared to 3-m/o WT mice (Fig. 2c) . Chronic catechin treatment prevented the accelerated decline in endothelium-dependent dilations with age in ATX mice and improved eNOS-H 2 O 2 production (Fig. 2b-c , Table 2 ). In 3-m/o WT mice, ACh-induced dilations were equally reduced in the presence of L-NNA or INDO, while FUR or APO had no effect (Fig. 3a-b, Table 2 ), suggesting a dilatory role for eNOS and prostacyclin. Accordingly, eNOS-H 2 O 2 production was abolished by L-NNA but unaffected by INDO, FUR, or APO (Fig. 3c) . In 12-m/o WT mice, the inhibitory effect of L-NNA was lower when compared to 3-m/o WT mice, suggesting the development of eNOS dysfunction with age (Fig. 3) . In addition, both INDO and FUR increased ACh dilations and H 2 O 2 -associated fluorescence in arteries from 12-m/o WT mice (Fig. 3, Table 2 ), suggesting an up-regulation of TXA 2 with age, counteracting the dilatory effect of eNOS.
Premature eNOS dysfunction in cerebral arteries from 3-m/o ATX mice was illustrated by the lower inhibitory effect of L-NNA on both dilation and H 2 O 2 production when compared to 3-m/o WT mice (Fig. 4, Table 2 ). This was (Fig. 4a-b, Table 2 ). Interestingly, INDO and FUR also improved eNOS-H 2 O 2 production (Fig. 4c) , suggesting that TXA 2 inhibits eNOS function.
In 12-m/o ATX mice, eNOS function was abolished since ACh dilations and H 2 O 2 -associated fluorescence were insensitive to L-NNA (Fig. 4, Table 2 ). ACh dilations in 12-m/o ATX mice were increased by FUR or INDO, although to a lesser extent than in 3-m/o ATX mice (Fig. 4a-b, Table 2 ). Neither INDO alone nor its combination with L-NNA altered H 2 O 2 production (Fig. 4c) . In addition, the fluorescent signal measured in the combined presence of L-NNA and INDO was associated with a significant vasodilation (Fig. 4b) , suggesting the implication of an EDHF [8] . Thus, the rise in H 2 O 2 -associated fluorescence induced by ACh was eNOS independent; it was, however, abolished by APO, a non-specific NADP(H) oxidase inhibitor, which had no effect in the other groups (Fig. 4c) . This is in accordance with the effects of APO on ACh-induced dilations, which only improved dilations in arteries isolated from 12-m/o ATX mice (Fig. 4, Table 2 ), suggesting that NADP(H) oxidase may contribute to endothelial dysfunction in these middle-aged atherosclerotic mice.
Following the chronic treatment with catechin, eNOS function was preserved: in cerebral arteries from 12-m/o ATX mice, both ACh dilations and H 2 O 2 -associated fluorescence became sensitive to L-NNA and were affected neither by INDO, nor FUR or APO (Fig. 4) , suggesting eNOS preservation and TXA 2 down-regulation. eNOS dysfunction and TXA 2 up-regulation observed with age and atherosclerosis are summarized in Fig. 5 . (Fig. 6a) , supporting the role of PGI 2 as an EDRF in these mice only. In ATX mice, the expression of the enzyme was significantly lower at 3 months of age compared to WT and was not further reduced with aging (Fig. 6a) . Catechin treatment did not reverse PGI 2 synthase protein level, in agreement with the functional data reported in Fig. 5 , where INDO had no inhibitory effect on the endotheliumdependent dilations. In contrast, TXA 2 synthase increased dramatically in middle-aged ATX mice (Fig. 6b) , an effect that was fully prevented by 9 months of treatment with catechin. This is in accordance with the functional data (Fig. 4) where catechin reversed the effects of FUR on eNOS function. Similarly, COX-1 and COX-2 expression rose with age in WT mice, and further in ATX mice ( Supplementary Fig. S2) ; catechin prevented the rise in COX-1 expression and normalized the rise in COX-2 expression to 3-m/o ATX level (Supplementary Fig. S2 ). Aging, atherosclerosis, or catechin affected the expression of neither eNOS nor iNOS protein in cerebral vessels ( Supplementary Fig. S3 ). Total expression of eNOS may, however, not be truly representative of eNOS function, unlike eNOS dimer/monomer ratio. We indeed previously showed that in mouse cerebral arteries, monomeric eNOS is the preferred state for the production of H 2 O 2 , although addition of BH 4 did not significantly increase the dimerization of eNOS, while it strongly increased NO production [8] .
Discussion
In the present study, we demonstrate for the first time that the age-related cerebral endothelial dysfunction in WT mice occurs prematurely in ATX mice. This endothelial dysfunction is associated with an up-regulation of TXA 2 , counteracting eNOS activity and the cerebrovascular dilation. This is accompanied by hypertension and severe peripheral conductance artery atheroma. Our data demonstrate that chronic preventive catechin treatment, a dietary cardioprotective polyphenol with antioxidant properties, reduces plaque size, normalizes blood pressure, and, most importantly, prevents the rise in TXA 2 synthase activity maintaining cerebral artery eNOS function.
In mouse cerebral arteries, we reported that the normal physiological function of eNOS is to generate dilatory H 2 O 2 -and not NO-in response to ACh [8] or to increases in intra-luminal flow [7] . In cerebral arteries of 12-m/o WT mice, endothelial dysfunction developed and eNOSassociated dilation and H 2 O 2 release were both reduced by ≈50%. PGI 2 synthase protein levels were decreased (Fig. 6a) , but INDO and FUR restored the normal dilatation. Therefore, in the cerebral arteries of middle-aged WT mice, H 2 O 2 and prostacyclin production decline due to a rise in TXA 2 synthase activity, as illustrated in Fig. 5 . This contrasts with the report that impaired cerebral dilations in aged rats are insensitive to INDO and thus not related to production of COX-derived constrictor metabolites [30] . In cerebral vessels isolated from 3-m/o ATX, the amplitude of the dilation associated with eNOS-derived H 2 O 2 was also reduced by ≈50%; both INDO and FUR restored the dilation and eNOS activity, while PGI 2 synthase expression was very low. Therefore, a similar deleterious profile is measured in young ATX and in middle-aged WT mice.
The early and reversible cerebral endothelial dysfunction observed in 3-m/o ATX mice is in sharp contrast with the almost complete loss of ACh-induced dilations in arteries isolated from 12-m/o ATX mice. In the latter, INDO and FUR only slightly improved dilations to ACh, but the production of H 2 O 2 was insensitive to L-NNA; this demonstrates that combined with severe dyslipidemia, aging leads to irreversible damages. Interestingly, in the presence of ACh, the rise in H 2 O 2 -associated fluorescence-but not the dilatory response-was abolished by apocynin, suggesting that in cerebral arteries isolated from 12-m/o ATX mice (unlike in any other groups), the NADP(H) oxidase is sensitive to muscarinic receptor activation. It has been shown that NADP (H) oxidase was partly responsible for flow-mediated dilation in rat brain arteries in vivo [39] , a mechanism absent in isolated mouse cerebral arteries [7] . Further studies including the measurement of NAD(P)H oxidase subunits expression are needed to clarify the exact role of this enzyme in the endothelial dysfunction observed in 12-m/o ATX mice. The rise in TXA 2 synthase and the potentially augmented NADP(H) oxidase activity in middle-aged ATX mice must contribute to the change in the redox environment. The increase in cerebrovascular NADP(H) oxidase activity in animal models of hypercholesterolemia was recently reported [20, 32] . Furthermore, it has been shown that aging limits the ability of antioxidant enzymes to upregulate in response to an acute and short-term proatherogenic challenge [3] . In our experimental conditions, however, this imbalance towards pro-oxidation was likely the result of a long-term pro-atherogenic stimulus leading to chronic damage [53] . This was indeed completely reversed by a chronic and long-term preventive treatment with catechin, a scavenger of superoxide anions [41, 50] . Catechin is, however, a non-specific antioxidant that displays large cardio-protective properties [45] , including anti-inflammatory properties [35, 52] . To achieve significant beneficial effects against cardiovascular diseases, frequent and habitual consumption of catechins present in green tea is required [35, 38, 54] . In the present study, beneficial functional effects of long-term chronic catechin treatment were associated with reduced aortic plaque formation and aortic oxidative stress (but not cerebral oxidative stress), as we previously reported [12] , and normalization of blood pressure in ATX mice. The catechin treatment preserved ACh-induced endothelium-dependent dilations to the level of arteries isolated from age-matched WT mice. This was associated with a lack of TXA 2 production or a potential contribution of NADP(H) oxidase during ACh stimulation, leading to the prevention of eNOS dysfunction. Catechins have been shown to modulate NOS activities, i.e., to inhibit iNOS and to [35, 50, 51] . There are numerous reports showing that antioxidants in general preserve or improve eNOS function either directly or by increasing NO bioavailability, and reduce the development of atherosclerosis and inflammation in mice models of dyslipidemia [4, 16, 58] . The beneficial role of antioxidants on the cerebral circulation, particularly in the context of atherosclerosis, is, however, less studied [20, 31, 32] .
Although previous studies suggested an association between TXA 2 and stroke or cerebral ischemia [2, 21, 43, 55] , the role of TXA 2 in cerebrovascular dysfunction associated with severe dyslipidemia and atherosclerosis is less clear [10] . Previous studies suggested that TXA 2 not only competes with but also lowers eNOS activity via an increase in ROS following receptor activation in renal arteries [13] , in cultured endothelial cells [57] , and in cerebral arteries [36] . In the present study, FUR increased endothelium-dependent dilations and reduced MT, suggesting a major role for TXA 2 in cerebral arteries from 12-m/o ATX mice.
In ATX mice, the reduction in TXA 2 synthase expression by catechin was accompanied by a strong reduction in plasma TXB 2 levels. Accordingly, TXA 2 production in platelets was reported to be inhibited by polyphenols [29] . The phenolic antioxidant AGI-1067 also decreased TXB 2 plasma levels without affecting PGI 2 production in patients with multiple risk factors for cardiovascular diseases [47] . It has also been previously reported that green tea extract was neuroprotective in rats exposed to ischemia/reperfusion by lowering eicosanoids brain concentration, including TXA 2 [19] .
Our study has some limitations: catechin and apocynin have potential non-specific effects that should also be considered. Catechin, used for 9 months, likely displays effects other than antioxidative properties [35] . Apocynin is a non-specific inhibitor of the NADP(H) oxidase, which may also act as a ROS scavenger [17, 46] . In addition, although used acutely in the present study, furegrelate, a specific TXA 2 synthase inhibitor, may affect the level of other prostaglandins besides TXA 2 . Finally, oxidative stress was assessed only by DHE staining, but the quantification of isoprostane levels could have been a more reliable index.
In conclusion, in our murine model of severe human dyslipidemia, atherosclerosis led to premature endothelial aging via eNOS dysfunction, an increase in TXA 2 production and oxidative stress (see Fig. 7 for summary). The impairment of eNOS function by oxidative stress could promote TXA 2 production, which would further contribute to the rise in ROS and endothelial dysfunction. Catechin, used in prevention, slowed the progression of atherosclerosis and the endothelial dysfunction via a reduction of the role of the TXA 2 pathway and thus the protection of the cerebrovascular eNOS function. Fig. 7 Schematic representation of the effects of age and severe dyslipidemia on the regulation of the cerebrovascular function and the preventive effects of catechin. Both aging and dyslipidemia favor the contribution of contractile TXA 2 which compromises endotheliumdependent cerebral dilation mediated through eNOS-derived H 2 O 2 . Aging and dyslipidemia are also associated with a rise in ROS, potentially originating from NADP(H) oxidase, which further impairs endothelial-dependent dilation via inhibition of the non-NO and non-PGI 2 
